Drs Marra and Goldenberg win innovation awards

Issue: BCMJ, vol. 50, No. 9, November 2008, Page 518 News

In September Drs Larry Goldenberg and Marco Marra were honored with 2008 British Columbia Innovation Council Awards. Dr Goldenberg was recognized with the BC Science and Technology Champion of the Year Award, while Dr Marra received the Frontiers in Research Award.

Dr Larry Goldenberg

As professor and head of the Department of Urologic Sciences at the University of British Columbia and clinical research director of the Prostate Centre at Vancouver General Hospital, Dr Goldenberg has contributed significantly to championing re­search by raising funds to create the infrastructure for the state-of-the art facility—a leading national Centre for Excellence in prostate research, education, and health care delivery programs. He also spearheaded the creation of the Department of Urological Sciences at UBC and pioneered the concept of intermittent hormone therapy for the management of prostate cancer, a treatment option regarded as the standard worldwide. His clinical and research work have garnered him an international reputation in raising awareness and excellence in prostate cancer research and treatment. Dr Goldenberg’s vision and leadership continue to play a pivotal role in advancing BC as a global leader in urology and prostate cancer research and treatment. 

Dr Marco Marra

As director of the Canada’s Michael Smith Genome Sciences Centre, Dr Marra is an internationally renowned expert in physical mapping and genome sequencing. His work focuses on cancer research, but his contributions also address other areas with global impact, including his work with the Human Genome Project and the sequencing of the SARS coronavirus—a discovery that initiated numerous activities within British Columbia to develop a vaccine and other therapeutics. In 1999 he established Canada’s Michael Smith Genome Sciences Centre in Vancouver, a state-of-the-art facility applying genomics and bioinformatics tools and technologies to cancer and disease research. Here, Dr Marra continues to raise the bar of research excellence by establishing the technology for a next-generation DNA sequencing platform, a powerful, leading-edge technology in the understanding of cancer genomics and the mountain pine beetle epidemic.

. Drs Marra and Goldenberg win innovation awards. BCMJ, Vol. 50, No. 9, November, 2008, Page(s) 518 - News.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply